These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17766736)

  • 41. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suspicion of duplicate publication regarding "J Anesth 2011; 25:953-4".
    Hirota K
    J Anesth; 2012 Apr; 26(2):320. PubMed ID: 22391669
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclodextrins and the emergence of sugammadex.
    Booij LH
    Anaesthesia; 2009 Mar; 64 Suppl 1():31-7. PubMed ID: 19222429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel pharmacological approaches for the antagonism of neuromuscular blockade.
    Pic LC
    AANA J; 2005 Feb; 73(1):37-40. PubMed ID: 15727282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergency use of sugammadex after failure of standard reversal drugs.
    Lenz A; Hill G; White PF
    Anesth Analg; 2007 Mar; 104(3):585-6. PubMed ID: 17312213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of rocuronium and sugammadex for caesarean delivery in a patient with myasthenia gravis.
    Garcia V; Diemunsch P; Boet S
    Int J Obstet Anesth; 2012 Jul; 21(3):286-7. PubMed ID: 22622006
    [No Abstract]   [Full Text] [Related]  

  • 50. Sugammadex: an opportunity to change the practice of anesthesiology?
    Miller RD
    Anesth Analg; 2007 Mar; 104(3):477-8. PubMed ID: 17312188
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors influencing the profile of onset of relaxation.
    De Mey JC; De Laat M
    Acta Anaesthesiol Belg; 1997; 48(1):7-10. PubMed ID: 9099302
    [No Abstract]   [Full Text] [Related]  

  • 55. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cyclodextrin. A new concept for antagonizing muscle relaxants].
    Sparr HJ
    Anaesthesist; 2002 Nov; 51(11):929-30. PubMed ID: 12434269
    [No Abstract]   [Full Text] [Related]  

  • 57. The pharmacology of rocuronium bromide (ORG 9426).
    Wicks TC
    AANA J; 1994 Feb; 62(1):33-8. PubMed ID: 8122487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of sugammadex self-association.
    Kurkov SV; Messner M; Lucassen M; van den Dobbelsteen DJ; den Engelsman J; Loftsson T
    Int J Pharm; 2011 Jul; 413(1-2):134-9. PubMed ID: 21539905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can sugammadex encapsulation eliminate the antigenic activity of aminosteroidal neuromuscular blocking agent?
    Kawano T; Yokoyama M
    J Anesth; 2011 Dec; 25(6):953-4. PubMed ID: 21904780
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sugammadex--a new agent for reversal of neuromuscular blockade].
    Claudius C; Gätke MR
    Ugeskr Laeger; 2009 Mar; 171(13):1091. PubMed ID: 19321086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.